chr5-132294929-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003059.3(SLC22A4):c.313C>G(p.Leu105Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003059.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A4 | NM_003059.3 | c.313C>G | p.Leu105Val | missense_variant | Exon 1 of 10 | ENST00000200652.4 | NP_003050.2 | |
SLC22A4 | XM_047417594.1 | c.313C>G | p.Leu105Val | missense_variant | Exon 1 of 8 | XP_047273550.1 | ||
SLC22A4 | XM_011543589.3 | c.313C>G | p.Leu105Val | missense_variant | Exon 1 of 8 | XP_011541891.1 | ||
SLC22A4 | XM_006714675.5 | c.-112C>G | 5_prime_UTR_variant | Exon 1 of 9 | XP_006714738.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A4 | ENST00000200652.4 | c.313C>G | p.Leu105Val | missense_variant | Exon 1 of 10 | 1 | NM_003059.3 | ENSP00000200652.3 | ||
P4HA2 | ENST00000471826.1 | n.138+249G>C | intron_variant | Intron 1 of 3 | 1 | |||||
P4HA2 | ENST00000431054.5 | c.78+249G>C | intron_variant | Intron 1 of 5 | 4 | ENSP00000391257.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.313C>G (p.L105V) alteration is located in exon 1 (coding exon 1) of the SLC22A4 gene. This alteration results from a C to G substitution at nucleotide position 313, causing the leucine (L) at amino acid position 105 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at